Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Metabolic, Inflammatory, Cognitive Risk Stratification, and Intensive Aerobic and Resistance Exercise Intervention for Middle-aged and Older Adults With Type 2 Diabetes Mellitus

NCT06401733 is registered in ClinicalTrials.gov with National University of Singapore as lead sponsor.

NCT NCT06401733
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06401733 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Metabolic, Inflammatory, Cognitive Risk Stratification, and Intensive Aerobic and Resistance Exercise Intervention for Middle-aged and Older Adults With Type 2 Diabetes Mellitus
Lead sponsor
National University of Singapore
Phase
Not applicable
Overall status
Completed
Start date
July 21, 2023
Completion date
March 31, 2025
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive dysfunction, cognitive impairment, non-insulin-dependent diabetes mellitus, type 2 diabetes mellitus